America's Next Gold Rush Is Gaining Speed

Record gold prices. Major partners in Nevada and Arizona. Billions in potential resources. The next chapter in America's gold story may already be unfolding - and one U.S. company is at the center of it.

Biogen Inc
NASDAQ:BIIB
$146.63
Open 143.31 Prev Close 143.00
High 147.47 Low 142.41
Volume 1,316,452 Volume (Avg) 1,611
52 Week High 187.58 52 Week Low 110.04
Market Cap 21.5B PE Ratio 14.03

General

NameBiogen Inc
TickerBIIB
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees7,605

About Biogen Inc

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS; and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, and biosimilars. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; and Sage Therapeutics, Inc., as well as collaborations with Fujirebio to identify and develop biomarkers for tau pathology in the brain and Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Highlights

Analyst Target171.96
Market Cap21,498,100,000
PE Ratio14.03
PEG Ratio6.24
EBITDA3,222,400,000

Valuation

Trailing PE13.68
Forward PE9.69
Price/Sales (Trailing 12 Mt.)2.10
Price/Book (Most Recent Quarter)1.29

Technicals

Beta0.09
52 Week High187.58
52 Week Low110.04
50 Day Average3.39%
200 Day Average8.45%

Earnings

Most Popular

Cathie Wood, Tom Lee Align On These 10 Stock Picks: Some Might Surprise You

A new ETF from Tom Lee shares 10 stocks in common with Cathie Wood's Ark Funds. A look at the stocks both well-known financial figures like.

On October 16, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad

When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.

Tim Cook To Depart, Steve Jobs' Lesson For Guy Kawasaki And More: This Week In Appleverse

From executive shake-ups at Apple to TSMC's revenue surge and Goldman's take on the AI boom, here are the top Apple stories.

US takes a minority stake company operating one of world's largest lithium mines in Nevada

The U.S. government is taking a minority stake in Lithium Americas, a company that is developing one of the world’s in northern Nevada.

VanEck and Kinross Both Have Their Eyes on This U.S. Gold Play - Ad

When a global fund manager and a $12B miner target the same domestic project, investors notice. Strategic deals and breakthrough drill results are fueling a surge of interest in this U.S. name.

Chinese leader Xi Jinping outlines 5-year plan at closed-door Communist Party meeting

BEIJING (AP) — Chinese leader Xi Jinping delivered a speech Monday on the opening day of of the ruling Communist Party to approve a draft plan laying out its goals for the country over the next five years.

MP Materials Tops List For Rare Earth Exposure, Says Analyst

Rare earth stocks are gaining attention as demand for magnets in EVs, robotics, and advanced air mobility is set to double by 2035.

The 7 Red Flags Wall Street Won't Talk About - Ad

All 7 historic crash signals are flashing red. Once the public notices, it's too late. Our free Bellwether Signal explains how to protect wealth - and why gold and silver have been the refuge in every crisis. Don't let your retirement go over a cliff.

The 7 Red Flags Wall Street Won't Talk About - Ad

All 7 historic crash signals are flashing red. Once the public notices, it's too late. Our free Bellwether Signal explains how to protect wealth - and why gold and silver have been the refuge in every crisis. Don't let your retirement go over a cliff.

Silver Nears $50 Amid Inventory Crisis, Outpacing Gold

Silver prices closed last week at multi-year highs, coming within reach of their 2011 peak of $49.95 per ounce.

Gold's Rally Is Rewriting America's Financial Story - Ad

As inflation lingers and governments wobble, gold keeps breaking records - and U.S. supply is suddenly back in focus. One domestic gold play is riding this trend on multiple fronts.

Tesla Stock Is Rallying Today: What's Behind The Move?

Tesla Inc (NASDAQ:TSLA) shares are trading higher on Monday after Evercore ISI raised its price target on the stock. The company also reportedly increased production at its Shanghai facility.

Trump Pushes Israel To Stop 'Bombing' Gaza As Hamas Agrees To Free Hostages: 'Right Now, It's Far Too Dangerous To Do That'

President Donald Trump welcomed Hamas's response to his proposed Gaza ceasefire plan on Friday, immediately calling on Israel to halt military operations in the enclave

The Best Case for Gold, Ever - Ad

With gold at record highs and Wall Street calling $6,600 next, a Trump-led "Mar-a-Lago Accord" could drive a historic revaluation. One pick with huge upside and lower risk is revealed in a free briefing - plus 3 actions to take before a 40% selloff.

NIO Stock Soars Past 52-Week High After Record Deliveries

NIO stock rises on strong September and Q3 deliveries, reaching record numbers and surpassing 52-week high.

Gold Deals Pick Up As Metal Soars Past $4,200

Gold reaches new highs, expected to continue rallying into 2026. Multiple mergers and acquisitions in gold market.

See Why Market Patterns Can Be Misleading - Ad

Crashes always give early warning - just not on CNBC. Our free Bellwether Signal report exposes the 7 indicators that preceded every collapse since 1929. All are red today. Protecting retirement may mean shifting to gold & silver, not more stocks.

Judge temporarily blocks the Trump administration from firing workers during the government shutdown

SAN FRANCISCO (AP) — President Donald Trump’s administration for now must stop firing workers during , a federal judge ordered on Wednesday.

Federal government to withhold $40M from California for not enforcing trucker English requirements

Transportation Secretary Sean Duffy said Wednesday he will withhold $40 million from California because it is the only state that is failing to enforce English language requirements for truckers.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

EPAM Joins Oracle To Boost AI And Cloud For Businesses

EPAM deepens partnership with Oracle to help companies in various sectors adopt OCI and AI services, leveraging their expertise.

Two Delta jets damaged in 'low-speed collision' on LaGuardia taxiway, injuring 1

Two Delta Air Lines regional jets collided on the taxiway at LaGuardia Airport in New York, injuring a flight attendant, damaging a cockpit and tearing off part of a wing in what the airline described as a “low-speed collision.”

A Worldwide Gold Lockdown Is Now Underway - Ad

Gold is being stockpiled worldwide - banks, nations, billionaires. This isn't "just gold." A detailed plan could impact savings, investments and even mortgages. The free broadcast breaks it down and shows what to do before it's too late.

Magnolia Oil & Gas Gets Upgrade On Strong Finances, Brighter Oil Outlook

KeyBanc raised Magnolia Oil & Gas to Overweight with a $29 target, citing a defensive profile and disciplined growth outlook.

America's Next Gold Rush Is Gaining Speed - Ad

Record gold prices. Major partners in Nevada and Arizona. Billions in potential resources. The next chapter in America's gold story may already be unfolding - and one U.S. company is at the center of it.

Faulty engineering led to implosion of Titan submersible headed to Titanic wreckage, NTSB finds

PORTLAND, Maine (AP) — Faulty engineering led to the implosion of an experimental submersible that killed five people on the way to the wreck of the , the National Transportation Safety Board concluded in a report Wednesday.

News organizations, including Hegseth's former employer Fox, reject new Pentagon reporting rules

Fox News, the former employer of Defense Secretary Pete Hegseth, has joined a near-unanimous outpouring of news organizations rejecting new rules for journalists based in the Pentagon.

On October 16, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad

When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.

Why Is BTQ Technologies Stock Up Today?

Shares of BTQ Technologies Corp. (NASDAQ:BTQ) are rising Thursday after the company announced that it reached a significant technological milestone.

VanEck and Kinross Both Have Their Eyes on This U.S. Gold Play - Ad

When a global fund manager and a $12B miner target the same domestic project, investors notice. Strategic deals and breakthrough drill results are fueling a surge of interest in this U.S. name.

Putin Stands up for Trump's Nobel Peace Prize Bid: 'Credibility Has Largely Been Lost'

Russian President Vladimir Putin has come forward in support of President Donald Trump's candidacy for the Nobel Peace Prize.

Domino's Growth Outlook Intact Despite Softer Q4 Trends, Analysts Say

Domino's Pizza Inc. (NYSE: DPZ) exceeded expectations and maintained 2025 guidance. TD Cowen and BTIG maintain Buy ratings.

The 7 Red Flags Wall Street Won't Talk About - Ad

All 7 historic crash signals are flashing red. Once the public notices, it's too late. Our free Bellwether Signal explains how to protect wealth - and why gold and silver have been the refuge in every crisis. Don't let your retirement go over a cliff.

Dutch Supreme Court rejects Russia's final appeal in $50B Yukos case

THE HAGUE, Netherlands (AP) — The Dutch Supreme Court on Friday rejected a final appeal by against a $50 billion arbitration award to former shareholders of Russian oil giant Yukos, who claimed Moscow deliberately bankrupted the company more than 20 years ago.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service